Infections and serious infections with ocrelizumab in relapsing multiple sclerosis and primary progressive multiple sclerosis

被引：0

作者：

Hartung, H. -P. ^{[1
]}

Arnold, D. L. ^{[2
,3
]}

Bar-Or, A. ^{[2
]}

Comi, G. ^{[4
]}

de Seze, J. ^{[5
]}

Giovannoni, G. ^{[6
]}

Hauser, S. L. ^{[7
]}

Hemmer, B. ^{[8
,9
]}

Kappos, L. ^{[10
]}

Lublin, F. ^{[11
]}

Montalban, X. ^{[12
]}

Rammohan, K. W. ^{[13
]}

Selmaj, K. ^{[14
]}

Traboulsee, A. ^{[15
]}

Chin, P. ^{[16
]}

Li, C. ^{[17
]}

Mairon, N. ^{[17
]}

Napieralski, J. ^{[17
]}

Wolinsky, J. ^{[18
]}

机构：

[1] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

[2] McGill Univ, Montreal, PQ, Canada

[3] NeuroRx Res, Montreal, PQ, Canada

[4] Univ Vita Salute San Raffaele, Milan, Italy

[5] Univ Hosp Strasbourg, Strasbourg, France

[6] Queen Mary Univ London, London, England

[7] Univ Calif San Francisco, San Francisco, CA 94143 USA

[8] Tech Univ Munich, Munich, Germany

[9] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[10] Univ Basel Hosp, Basel, Switzerland

[11] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[12] Vall Hebron Univ Hosp, Barcelona, Spain

[13] Univ Miami, Miami, FL USA

[14] Med Univ Lodz, Lodz, Poland

[15] Univ British Columbia, Vancouver, BC, Canada

[16] Genentech Inc, San Francisco, CA 94080 USA

[17] F Hoffmann La Roche Ltd, Basel, Switzerland

[18] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1248

引用

页码：658 / 659

页数：2

共 50 条

[21] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Prajapati, K.
Koendgen, H.
Craveiro, L.
Hughes, R.
Pradhan, A.
Wolinsky, J.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 68 - 69
[22] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
Kappos, Ludwig
Hauser, Stephen
Montalban, Xavier
Buffels, Regine
Chin, Peter
Li, Carrie
Mortensen, Deborah
Napieralski, Julie
Van Beek, Johan
Wormser, David
Wolinsky, Jerry
NEUROLOGY, 2017, 88
[23] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S.
Kappos, L.
Montalban, X.
Craveiro, L.
Hughes, R.
McNamara, J.
Pradhan, A.
Wormser, D.
Koendgen, H.
Wolinsky, J. S.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
[24] Ocrelizumab for primary progressive multiple sclerosis
Adler, Ai
Knight, H.
LANCET NEUROLOGY, 2019, 18 (09): : 816 - 817
[25] Ocrelizumab for primary progressive multiple sclerosis
Montalban X
Hauser SL
Kappos L
中华物理医学与康复杂志, 2017, (03) : 174 - 174
[26] Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study
Knapp, Rachel
Hardtstock, France
Krieger, Julia
Wilke, Thomas
Maywald, Ulf
Chognot, Cathy
Muros-Le Rouzic, Erwan
Craveiro, Licinio
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
[27] Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study
Knapp, Rachel
Hardtstock, Fraence
Krieger, Julia
Wilke, Thomas
Maywald, Ulf
Chognot, Cathy
Rouzic, Erwan Muros-Le
Craveiro, Licinio
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
[28] Beyond ocrelizumab in primary progressive multiple sclerosis
Thomas Williams
Jeremy Chataway
Nature Reviews Neurology, 2022, 18 : 641 - 642
[29] Beyond ocrelizumab in primary progressive multiple sclerosis
Williams, Thomas
Chataway, Jeremy
NATURE REVIEWS NEUROLOGY, 2022, 18 (11) : 641 - 642
[30] Effect of Ocrelizumab on Thalamic Atrophy in Patients with Relapsing and Primary Progressive Multiple Sclerosis
Arnold, Douglas L.
Sprenger, Till
Bar-Or, Amit
Wolinsky, Jerry S.
Kappos, Ludwig
Kolind, Shannon
Manfrini, Marianna
Magon, Stefano
van Beek, Johan
Koendgen, Harold
Bernasconi, Corrado
Gaetano, Laura
Traboulsee, Anthony
NEUROLOGY, 2020, 94 (15)

← 1 2 3 4 5 →